EFFICACY OF TOCILIZUMAB IN 31 PATIENTS WITH GIANT CELL ARTERITIS

被引:0
|
作者
Dominguez-Casas, L. C. [1 ]
Loricera, J. [1 ]
Hernandez, J. L. [2 ]
Castaneda, S. [3 ]
Mera, A. [4 ]
Perez-Pampin, E. [4 ]
Peiro, E. [1 ]
Humbria, A. [3 ]
Calvo-Alen, J. [5 ]
Aurrecoechea, E. [5 ]
Narvaez, J. [6 ]
Sanchez-Andrade, A. [7 ]
Vela, P. [8 ]
Diez, E. [9 ]
Mariano, C. [9 ]
Lluch, P. [10 ]
Moll, C. [10 ]
Hernandez, I. [11 ]
Calvo-Rio, V. [1 ]
Ivorra, J. [12 ]
Corrales, A. [1 ]
Ortiz-Sanjuan, F. [12 ]
Gonzalez-Vela, C. [1 ]
Gonzalez-Gay, M. A. [1 ]
Blanco, R. [1 ]
机构
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Rheumatol, Santander, Spain
[2] Hosp Univ Marques de Valdecilla, IDIVAL, Internal Med, Santander, Spain
[3] Hosp Univ Princesa, Rheumatol, IIS IP, Madrid, Spain
[4] Complejo Hosp Univ Santiago, Rheumatol, Santiago De Compostela, Spain
[5] Hosp Sierrallana, Rheumatol, Torrelavega, Spain
[6] Hosp Bellvitge Princeps Espanya, Rheumatol, Barcelona, Spain
[7] Hosp Univ Lucus Augusti, Rheumatol, Lugo, Spain
[8] Hosp Gen Univ Alicante, Rheumatol, Alicante, Spain
[9] Complejo Asistencial Univ Leon, Rheumatol, Leon, Spain
[10] Hosp Mateu Orfila, Rheumatol, Menorca, Spain
[11] Complexo Hosp Univ Vigo, Rheumatol, Vigo, Spain
[12] Hosp Univ & Politecn la Fe, Rheumatol, Valencia, Spain
关键词
D O I
10.1136/annrheumdis-2017-eular.3262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0336
引用
收藏
页码:614 / 614
页数:1
相关论文
共 50 条
  • [31] Benchmarking tocilizumab use for giant cell arteritis
    Conway, Richard
    Putman, Michael S.
    Mackie, Sarah L.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (02)
  • [32] Trial of Tocilizumab in Giant-Cell Arteritis
    Walker, Ulrich A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15): : 1493 - 1493
  • [33] Design of the Tocilizumab in Giant Cell Arteritis Trial
    Unizony, Sebastian H.
    Dasgupta, Bhaskar
    Fisheleva, Elena
    Rowell, Lucy
    Schett, Georg
    Spiera, Robert
    Zwerina, Jochen
    Harari, Olivier
    Stone, John H.
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2013, 2013
  • [34] Tocilizumab for giant cell arteritis: what is optimal?
    Kaymakci, M.
    Warrington, K. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 777 - 779
  • [35] Tocilizumab for giant cell arteritis: an amazing result
    Metin Işık
    Levent Kılıç
    İsmail Doğan
    Meral Çalgüneri
    Rheumatology International, 2013, 33 : 2961 - 2962
  • [36] GIANT CELL ARTERITIS. TREATMENT WITH TOCILIZUMAB
    Aldasoro Caceres, Vicente
    Mendizabal Mateos, Javier
    Garcia Perez, Sara
    Paniagua Zudaire, Inmaculada
    Fito Manteca, Concepcion
    Horcada Rubio, Loreto
    Del Val Del Amo, Natividad
    Gutierrez Polo, Ricardo
    Garrido Courel, Laura
    Restrepo Velez, Juliana
    Ibanez Bosch, Rosario
    Loza Cortina, Eduardo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S12 - S12
  • [37] Trial of Tocilizumab in Giant-Cell Arteritis
    Stone, J. H.
    Tuckwell, K.
    Dimonaco, S.
    Klearman, M.
    Aringer, M.
    Blockmans, D.
    Brouwer, E.
    Cid, M. C.
    Dasgupta, B.
    Rech, J.
    Salvarani, C.
    Schett, G.
    Schulze-Koops, H.
    Spiera, R.
    Unizony, S. H.
    Collinson, N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 317 - 328
  • [38] Tocilizumab for giant cell arteritis: an amazing result
    Isik, Metin
    Kilic, Levent
    Dogan, Ismail
    Calguneri, Meral
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2961 - 2962
  • [39] Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients
    Regola, Francesca
    Cerudelli, Elisabetta
    Bosio, Giovanni
    Andreoli, Laura
    Tincani, Angela
    Franceschini, Franco
    Toniati, Paola
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2020, 4 (02)
  • [40] ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB
    Calderon-Goercke, Monica
    Loricera, J.
    Prieto-Pena, D.
    Aldasoro, Vicente
    Castaneda, Santos
    Villa-Blanco, Ignacio
    Humbria, Alicia
    Moriano, Clara
    Romero-Yuste, Susana
    Narvaez, J.
    Gomez-Arango, Catalina
    Perez-Pampin, Eva
    Melero, Rafael
    Becerra-Fernandez, Elena
    Revenga, Marcelino
    Alvarez-Rivas, Noelia
    Galisteo, Carles
    Sivera, Francisca
    Olive, Alejandro
    Alvarez del Buergo, Maria
    Marena Rojas, Luisa
    Fernandez-Lopez, Carlos
    Navarro, Francisco
    Raya, Enrique
    Galindez, Eva
    Arca, Beatriz
    Solans-Laque, Roser
    Conesa, Arantxa
    Hidalgo, Cristina
    Vazquez, Carlos
    Andres Roman-Ivorra, Jose
    Lluch, Pau
    Manrique Arija, Sara
    Vela-Casasempere, Paloma
    de Miguel, Eugenio
    Torres-Martin, Carmen
    Carlos Nieto, Juan
    Ordas-Calvo, Carmen
    Salgado-Perez, Eva
    Luna-Gomez, Cristina
    Toyos Saenz de Miera, J. Francisco.
    Fernandez-Llanio, Nagore
    Garcia, Antonio
    Larena, Carmen
    Palmou-Fontana, Natalia
    Calvo-Rio, Vanesa
    Gonzalez-Vela, Carmen
    Corrales, Alfonso
    Varela-Garcia, Maria
    Aurrecoechea, Elena
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 819 - 819